TENOFOVIR DISOPROXIL FUMARATE

Other

Brand names: Tenofovir Disoproxil Fumarate

Pregnancy: Category BOral

12.1 Mechanism of Action Tenofovir disoproxil fumarate is an antiviral drug [See Microbiology ( 12.4 )].

BIKTARVY ®

COMPLERA ®

DESCOVY ®

GENVOYA ®

ODEFSEY ®

STRIBILD ®

Contraindications

5 WARNINGS AND PRECAUTIONS • New onset or worsening renal impairment: Can include acute renal failure and Fanconi syndrome
In patients at risk for renal dysfunction, assess estimated creatinine clearance, serum phosphorus, urine glucose, and urine protein before initiating treatment with tenofovir disoproxil fumarate tablets and periodically during treatment
5) • Decreases in bone mineral density (BMD): Consider assessment of BMD in patients with a history of pathologic fracture or other risk factors for osteoporosis or bone loss
In patients at risk of renal dysfunction, including patients who have previously experienced renal events while receiving HEPSERA ®, it is recommended that estimated creatinine clearance, serum phosphorus, urine glucose, and urine protein be assessed prior to initiation of tenofovir disoproxil fumarate tablets, and periodically during tenofovir disoproxil fumarate tablets therapy

1 documented side effects by frequency

Anxiety

1-10%

No community discussions found for TENOFOVIR DISOPROXIL FUMARATE yet.

0 available comparisons

No comparisons yet.

Dosage Forms

Tablet

Route

Oral